Summary & Overview
HCPCS Level II J0610: Injection, Calcium Gluconate 10 ml
HCPCS Level II code J0610 denotes a 10 ml vial of calcium gluconate (Fresenius Kabi) intended for parenteral administration. This product-level code matters nationally because calcium replacement and emergent calcium therapies are common across inpatient and outpatient settings, and accurate coding of the drug product and unit quantity affects clinical documentation, billing consistency, and payer adjudication. Major national payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what J0610 represents clinically and operationally, the typical sites of service where it is used, and how payers commonly approach coverage and billing for injectable calcium products. The publication provides benchmarks and policy context relevant to charge capture, unit reporting, and payer coverage patterns, and summarizes common modifiers and claim considerations where available. It also highlights areas where coding clarity influences payment recovery and clinical record alignment. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J0610 represents an injection of calcium gluconate (Fresenius Kabi), per 10 ml. This supply-based code is used to bill for the drug formulation specified in the description when administered to a patient.
Service Type: Parenteral medication administration / drug supply
Typical Site of Service: Inpatient hospital, outpatient hospital, emergency department, or other clinical settings where intravenous or intramuscular medications are administered (clinic or physician office as applicable)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department or outpatient infusion center with symptomatic hypocalcemia (e.g., perioral numbness, muscle cramps, tetany) or for reversal of calcium channel blocker toxicity. The clinician assesses vital signs and performs point-of-care testing or draws serum chemistries showing low corrected calcium or ionized calcium. Following confirmation and indication, intravenous calcium gluconate J0610 is prepared (commonly 10 mL vials) and administered by an emergency physician, hospitalist, or infusion nurse via peripheral IV or central line. Documentation includes indication, dose administered, route, time, patient response, and any adverse reactions. Observation and repeat calcium measurement are performed as clinically indicated; additional supportive care such as cardiac monitoring is used for severe cases or calcium channel blocker overdose.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Professional component | When reporting the physician professional component separate from facility billing (rare for drug J-codes billed by provider) |
22 |